Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 2 Study of Sildenafil for the Treatment of Lymphatic Malformations

NCT02335242 is registered in ClinicalTrials.gov with Stanford University as lead sponsor.

NCT NCT02335242
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02335242 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 2 Study of Sildenafil for the Treatment of Lymphatic Malformations
Lead sponsor
Stanford University
Phase
Phase 2
Overall status
Completed
Start date
May 23, 2015
Completion date
March 30, 2021
Enrollment
22 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

lymphatic diseases, lymphatic malformations